Where Are the Sentinel Lymph Nodes Located?

Learn where sentinel lymph nodes are located, their critical role as cancer gatekeepers, and how doctors find them using mapping technology.

Sentinel lymph nodes do not sit in one fixed spot in the body. They are defined by their function, not their address: a sentinel node is whatever lymph node first receives drainage from a particular tumor. That means the location shifts depending on where the cancer is growing and how that region’s lymphatic vessels are wired. For breast cancer, sentinel nodes cluster in the armpit. For melanoma on the leg, they show up in the groin. For cervical or endometrial cancer, they lie deep in the pelvis. The concept is consistent, but the geography changes with every tumor site.

What Makes a Lymph Node “Sentinel”

The word sentinel means lookout or guard, and in cancer surgery, a sentinel lymph node is the first node to receive lymphatic fluid draining directly from a tumor. If cancer cells are going to spread through the lymphatic system, they almost always pass through this gatekeeper node before reaching any others. That is why surgeons biopsy it: if the sentinel node is clean, the rest of the regional nodes are very likely clean too, and the patient can often be spared a larger operation. The sentinel node concept was validated through studies in the 1990s showing that cancer tends to spread through the lymphatic system in an orderly, stepwise fashion rather than skipping around randomly.

Because sentinel nodes are defined by drainage patterns, a person can have more than one sentinel node for a single tumor. Some tumors drain through two or three lymphatic channels at once, each leading to a different first-stop node. Surgeons typically remove all nodes that light up during the mapping procedure, whether that turns out to be one, two, or occasionally more.

Breast Cancer and the Armpit

Breast cancer is the setting where most people encounter the term “sentinel node,” and for good reason: sentinel node biopsy largely replaced full axillary lymph node dissection as the standard way to stage the disease. The vast majority of breast sentinel nodes sit in the lower part of the armpit, an area surgeons call level I of the axilla. In a study of over 400 breast cancer cases, sentinel nodes were found exclusively in level I in about 97% of patients. A separate study using MRI similarly found that when a single lymph node was involved, it was one of the lowest nodes in the axilla in over 96% of patients.

But the armpit is not the only place breast sentinel nodes appear. Roughly a quarter of patients show additional drainage to the internal mammary chain, a row of small nodes tucked behind the breastbone alongside the internal mammary artery. One landmark study found extra hot spots in the internal mammary chain in about 25% of patients, with those nodes sitting most often in the second through fifth intercostal spaces (the gaps between the ribs). Internal mammary drainage was more common with tumors in the inner or central parts of the breast, but it also showed up with lateral tumors about a third of the time. The lymphatic flow in this chain proceeds stepwise from one internal mammary node to the next, much the way it does in the axilla.

Why does the internal mammary location matter? Because a cancer that has spread to an internal mammary node but not to the axilla would be missed entirely if the surgeon only checked the armpit. In one reported case, a patient’s axillary sentinel node was negative while the internal mammary sentinel node harbored micrometastases, a finding that changed the staging and treatment plan. In practice, not every surgical team routinely biopsies internal mammary nodes; the decision often depends on preoperative imaging results and the location of the primary tumor.

Melanoma on the Trunk, Limbs, and Head

Melanoma is a cancer where sentinel node location is famously unpredictable, especially when the primary tumor grows on the trunk. A melanoma on the back could drain to one armpit, both armpits, the groin, or some combination. The most frequent drainage site for trunk melanomas is the axilla, and positive sentinel nodes also turn up there more often than in other basins, even for melanomas on the lower trunk. Trunk melanomas are also far more likely than extremity melanomas to drain to multiple node basins simultaneously: about 31% of trunk melanoma patients had sentinel nodes in more than one region, compared with 7% of extremity patients.

Extremity melanomas are more straightforward. A melanoma on the lower leg almost always drains to the inguinal (groin) nodes. One on the forearm drains to the axilla. There are occasional surprises, like popliteal (behind-the-knee) or epitrochlear (inner-elbow) sentinel nodes, but these are uncommon.

Head and neck melanomas present the biggest mapping challenge. The lymphatic network in the head and neck is dense and tangled, and drainage can reach cervical nodes at several different levels. One cohort study found that head and neck melanoma had the highest rate of complex drainage of any body site, with about 49% of patients showing sentinel nodes in multiple lymph node groups and roughly 29% lighting up three or more separate hot spots on imaging. For this reason, preoperative imaging with hybrid SPECT/CT is especially valuable for head and neck cases, since conventional flat images often miss sentinel nodes that sit close to the injection site or in unexpected locations.

Pelvic Sentinel Nodes in Gynecological Cancers

For cervical and endometrial cancers, sentinel nodes live in the pelvis. Two locations dominate. The most common is the obturator fossa, a depression along the side wall of the pelvis near the obturator nerve. The second most common is the internal iliac or interiliac area, near the junction of the major blood vessels supplying the pelvis. Together, these two spots account for roughly 83–85% of all metastatic sentinel nodes in both cervical and endometrial cancer, with no significant difference between the two cancer types.

A large endometrial cancer cohort confirmed this pattern. Out of 526 identified sentinel nodes, about 49% were in the obturator region and 25% in the internal iliac area. Bilateral detection, meaning at least one sentinel node found on each side of the pelvis, was achieved in 87% of patients. A small fraction of sentinel nodes (about 1.5%) turned up in the para-aortic region, higher along the aorta and outside the usual pelvic dissection field. Those para-aortic sentinel nodes carried a disproportionately high risk of containing cancer, which underscores the value of preoperative mapping even in a cancer type where sentinel node locations are fairly consistent.

Oral and Throat Cancers

In early-stage oral cancers, sentinel nodes are found in the cervical lymph node levels of the neck, most often at level II (the upper jugular region), which accounts for roughly 20–57% of sentinel nodes across studies. The sentinel node is not necessarily the one closest to the tumor; a cancer on the tongue, for instance, may drain past nearby level I nodes and light up a level II or level III node instead.

A particularly tricky feature of oral cancer is contralateral drainage. Tumors near the midline of the mouth, especially on the floor of the mouth, can send lymphatic fluid across to nodes on the opposite side of the neck. One study found that about 8% of patients had contralateral sentinel nodes and another 8% had bilateral ones. In a separate series, all patients with true midline tumors drained to both sides of the neck. Missing the contralateral sentinel node could mean understaging the disease, so bilateral mapping is now standard for midline oral tumors.

Prostate and Gastrointestinal Cancers

Sentinel node mapping in prostate cancer is less routine than in breast cancer or melanoma, but research has mapped out the principal drainage routes. Three characteristic lymphatic pathways from the prostate have been identified, and about 91% of positive sentinel nodes fell at two specific sites along those pathways: one at the junction between the internal and external iliac vessels, and the other along the inferior vesical artery, a branch of the internal iliac.

Gastrointestinal cancers present a different challenge. The sentinel node is identified intraoperatively by injecting dye around the tumor and watching which nearby mesenteric lymph node picks up the color first. In about 8% of gastrointestinal cancer patients in one series, sentinel node mapping revealed drainage to an unexpected location, such as a node on the wrong side of a major artery or higher up in the mesentery than anticipated. In each of those cases, the finding changed the planned surgical approach, sometimes converting a limited bowel resection into a wider one. A similar sentinel node approach has been studied in esophageal cancer, where a meta-analysis across 23 studies reported an overall detection rate of about 93%.

How Surgeons Find Sentinel Nodes

Three main tools are used, often in combination. A radioactive tracer (usually technetium-99m attached to tiny particles) is injected near the tumor before or during surgery. The tracer travels through the lymphatic channels and collects in the sentinel node, which can then be detected with a handheld gamma probe. Blue dye (methylene blue or patent blue) offers a visual backup: the surgeon looks for any node that has turned blue. And indocyanine green (ICG), a fluorescent dye visible under near-infrared light, has become increasingly popular because the surgeon can actually trace the green glow along lymphatic channels beneath the skin before it pools in the sentinel node.

Combining two tracers improves the detection rate. In vulvar cancer, for example, using radiotracer plus blue dye together yielded successful mapping in about 87% of sentinel node biopsy attempts. In endometrial cancer, combining ICG with a radiotracer or patent blue helped recover sentinel nodes that preoperative mapping had missed.

When Preoperative Imaging Changes the Plan

Flat, two-dimensional images from conventional lymphoscintigraphy (a gamma-camera picture taken after injecting the radiotracer) are often enough for straightforward cases like a lateral breast tumor or a limb melanoma. But for cancers with complex drainage, hybrid SPECT/CT scanning before surgery can reveal sentinel nodes that flat images miss. A meta-analysis comparing SPECT/CT to planar lymphoscintigraphy in breast cancer found that SPECT/CT detected sentinel nodes in about 92% of patients versus about 85% for planar scans alone. SPECT/CT is especially recommended in head and neck melanoma, breast cancers with extra-axillary drainage, and any tumor draining to the pelvis, where overlapping anatomy makes flat images ambiguous.

What Can Shift Sentinel Node Location

Prior treatment is the biggest factor that reroutes lymphatic drainage. If you have already had surgery or radiation therapy on one side of the body, the normal lymphatic channels may be scarred shut, forcing fluid to travel through alternate routes. This matters most in breast cancer recurrences. In patients who had received prior radiation, aberrant drainage was found in 60% of cases, compared with 19% in patients who had not been irradiated. The most dramatic shift was drainage to the opposite armpit, which appeared in about 52% of previously irradiated patients versus only 2% of those without prior radiation.

This is a major reason that repeat sentinel node mapping cannot simply rely on assumptions from the first surgery. The drainage map may have been completely redrawn by the prior treatment, and the new sentinel node may sit in a basin the surgeon would never have checked without fresh imaging.

Sentinel Node Biopsy in Children

Sentinel node mapping is not limited to adult cancers. In pediatric Wilms tumor (a kidney cancer in young children), researchers have applied the technique and found that a single sentinel node was detected in most patients, with the most common location being the inter-aortocaval space, the gap between the aorta and the inferior vena cava in the retroperitoneum. Among 20 patients studied, about 15% of sentinel nodes contained tumor. The technique remains investigational in most pediatric solid tumors, but it illustrates how the sentinel concept adapts to each cancer’s unique anatomy.

Why the Number of Sentinel Nodes Matters

Surgeons do not always find just one sentinel node. The number removed can influence staging accuracy. In a breast cancer cohort of 684 patients, about 29% had at least one positive sentinel node. Of those with positive findings, roughly 90% had cancer in just a single sentinel node, about 10% had two involved, and one patient had three. Tumor factors like lymphovascular invasion and size above 20 mm were the strongest predictors of sentinel node involvement. The practical point for patients: finding one positive sentinel node does not automatically mean cancer has spread widely, and in many situations additional surgery beyond sentinel node removal may not be needed.